We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Phoenix Group Holdings Plc | LSE:PHNX | London | Ordinary Share | GB00BGXQNP29 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-8.00 | -1.55% | 509.50 | 509.50 | 510.00 | 519.00 | 506.50 | 518.50 | 1,464,441 | 14:42:16 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Life Insurance | 22.81B | -116M | -0.1159 | -43.92 | 5.1B |
TIDMPHNX
RNS Number : 6363N
Phoenix Group Holdings
10 May 2018
Phoenix Group Holdings (the "Company" or "Phoenix")
In compliance with Listing Rule 9.6.14, the Company announces that with effect from 9 May 2018, Kory Sorenson, a non-executive director of the Company, has been appointed as a non-executive director of ProMetic Life Sciences Inc., whose shares are listed on the Toronto Stock Exchange.
Enquiries
Equity Investors/Analysts:
Claire Hawkins, Head of Investor Relations, Phoenix
+44 (0) 20 3735 0575
Media:
Neil Bennett, Maitland
+44 (0) 20 7379 5151
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDNMMGMKRGNGRZG
(END) Dow Jones Newswires
May 10, 2018 04:30 ET (08:30 GMT)
1 Year Phoenix Chart |
1 Month Phoenix Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions